Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
256 results
D1.112 - Managing patients with Type 2 inflammation in a joint interdisciplinary “United Airways Clinic” at Lund University Hospital, Sweden
D1.113 - Severe Asthma and Depression: the Overlooked Burden
D1.114 - The Hidden Costs of Severe Asthma Treatment: Unveiling the Iatrogenic Burden
D1.115 - Post-emergency asthma management
D1.88 - Mepolizumab and intestinal parasitic infection: A case report
D1.91 - Baseline characteristics and main clinical outcomes of patients receiving tezepelumab in the framework of use in Special Situations prior to commercialization in Spain (T-ROSS Study)
D1.92 - Results from the EGPAware Delphi study on Red Flags for Suspicion of Eosinophilic Granulomatosis with Polyangiitis (EGPA): current management in Europe
D1.93 - ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
D1.94 - Impact of overweight and obesity on clinical remission and Response to Biologics in Severe Asthma Patients
D1.95 - Dupilumab-induced eosinophilia: a transient effect
D1.96 - Impact of Dupilumab-induced Eosinophilia on Pulmonary Function Tests and Patient Reported Outcomes Measures (PROMs)
D1.99 - Exploring the relationship between 6 minutes walk test (6MWT) performance and lung function in Severe Asthma and CRSwNP
D2.102 - Adult Gut Microbiota and Metabolomics in Different Phenotypes of Asthma
D2.103 - Exploring association between lung function, asthma and epigenetic predisposition to obesity
D2.104 - Dissecting the molecular mechanisms underlying TSLP-driven non-type 2 inflammatory responses in severe asthma
D2.105 - Clinical remission of severe asthma: 5-year follow-up
D2.106 - Molecular Clustering Using microRNA Expression Profiles in Pediatric Asthma Reveals Differential Corticosteroid Responsiveness
D2.107 - Effect of n-3 long-chain polyunsaturated fatty acid and vitamin D supplementation on human lung organoids
D2.108 - Real-life experience after 6 months with Tezepelumab in specialized asthma units across northern Spain
D2.109 - Interleukin-17A gene polymorphism contribute to the elderly asthma susceptibility: evidences from a case-control study
Pagination
First page
First
Previous page
Previous
…
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Current page
12
Page
13
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download